Nuveen
ABBV icon

Nuveen’s AbbVie ABBV Stock Holding History

Nuveen’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-43,200
Closed -$5K – 3316
2021
Q3 		$5K Buy
+43,200
New +$4.94M ﹤0.01% 3346
2021
Q2 		– Sell
-49,500
Closed -$5K – 3349
2021
Q1 		$5K Buy
+49,500
New +$5.29M ﹤0.01% 3323
2020
Q2 		– Sell
-51,100
Closed -$4K – 3266
2020
Q1 		$4K Buy
+51,100
New +$4.35M ﹤0.01% 3158

Other funds holding ABBV

State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $483B AUM 27.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Nuveen's ABBV Position: Q3 2026 in Review

Nuveen increased its AbbVie (ABBV) stake by 2.4% in Q3 2026, buying an estimated $57.7M and bringing the position to 9,735,091 shares worth $2.55B. The position accounts for 0.61% of the portfolio, ranked #25.

Nuveen first reported a position in ABBV in Q2 2013 and has held it in 54 quarters since. The position peaked at $2.62B in Q1 2022. 3,450 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Nuveen held 9,735,091 shares of AbbVie worth $2.55B as of Q3 2026.
  • Nuveen bought 225,100 AbbVie shares in Q3 2026, an estimated $57.7M.
  • AbbVie made up 0.61% of Nuveen's portfolio in Q3 2026, its #25 holding.
  • Nuveen first reported a position in AbbVie in Q2 2013 and has held it in 54 quarters since.
  • Nuveen's AbbVie position peaked at $2.62B in Q1 2022.
  • 3,450 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Nuveen's 13F filing for Q3 2026, filed 10 Nov 2026.